| Dr Bobby Clayton Howard, MD | |
|
1924 Alcoa Hwy, South 6-south, Knoxville, TN 37920-1511 | |
| (865) 305-8888 | |
| (865) 305-2514 |
| Full Name | Dr Bobby Clayton Howard |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 31 Years |
| Location | 1924 Alcoa Hwy, Knoxville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144200064 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| High Risk Obstetrical Consultants, Pllc | 8729137021 | 8 |
News Archive
Nycomed announced today that Judge Jose L. Linares of the U.S. District Court for the District of New Jersey has confirmed the jury verdict in favor of Nycomed and Pfizer Inc. The decision upholds the jury verdict issued on April 23, 2010, confirming that the patent is valid and rejecting allegations by the defendants that the patent was invalid as obvious and invalid for double patenting. Against KUDCo, the US generic drug business of the Schwarz Pharma Group, which did not at-risk launch, final Judgment was entered as a result of Judge Jose L. Linares' rulings.
Before you swat away the next fruit fly, consider instead just how similar its biological complexities are to our own.
On 21 February Bill Gates met with Dr. Carlos Martin of the University of Zaragoza and members of his team in Madrid, Spain. The scientists are working on the development of MTBVAC, a new vaccine against tuberculosis (TB). Gates showed great interest in the scientific background of MTBVAC, the most advanced vaccine based on attenuation of Mycobacterium tuberculosis.
Oxis International, Inc., a biotechnology company focused on cancer therapy development and commercialization, announced today that trading in its common stock will resume on Euronext Paris on April 14, 2015.
› Verified 5 days ago
| Entity Name | University Of Tennessee |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295751386 PECOS PAC ID: 3072421213 Enrollment ID: O20040110000145 |
News Archive
Nycomed announced today that Judge Jose L. Linares of the U.S. District Court for the District of New Jersey has confirmed the jury verdict in favor of Nycomed and Pfizer Inc. The decision upholds the jury verdict issued on April 23, 2010, confirming that the patent is valid and rejecting allegations by the defendants that the patent was invalid as obvious and invalid for double patenting. Against KUDCo, the US generic drug business of the Schwarz Pharma Group, which did not at-risk launch, final Judgment was entered as a result of Judge Jose L. Linares' rulings.
Before you swat away the next fruit fly, consider instead just how similar its biological complexities are to our own.
On 21 February Bill Gates met with Dr. Carlos Martin of the University of Zaragoza and members of his team in Madrid, Spain. The scientists are working on the development of MTBVAC, a new vaccine against tuberculosis (TB). Gates showed great interest in the scientific background of MTBVAC, the most advanced vaccine based on attenuation of Mycobacterium tuberculosis.
Oxis International, Inc., a biotechnology company focused on cancer therapy development and commercialization, announced today that trading in its common stock will resume on Euronext Paris on April 14, 2015.
› Verified 5 days ago
| Entity Name | High Risk Obstetrical Consultants, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770724676 PECOS PAC ID: 8729137021 Enrollment ID: O20161116003031 |
News Archive
Nycomed announced today that Judge Jose L. Linares of the U.S. District Court for the District of New Jersey has confirmed the jury verdict in favor of Nycomed and Pfizer Inc. The decision upholds the jury verdict issued on April 23, 2010, confirming that the patent is valid and rejecting allegations by the defendants that the patent was invalid as obvious and invalid for double patenting. Against KUDCo, the US generic drug business of the Schwarz Pharma Group, which did not at-risk launch, final Judgment was entered as a result of Judge Jose L. Linares' rulings.
Before you swat away the next fruit fly, consider instead just how similar its biological complexities are to our own.
On 21 February Bill Gates met with Dr. Carlos Martin of the University of Zaragoza and members of his team in Madrid, Spain. The scientists are working on the development of MTBVAC, a new vaccine against tuberculosis (TB). Gates showed great interest in the scientific background of MTBVAC, the most advanced vaccine based on attenuation of Mycobacterium tuberculosis.
Oxis International, Inc., a biotechnology company focused on cancer therapy development and commercialization, announced today that trading in its common stock will resume on Euronext Paris on April 14, 2015.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bobby Clayton Howard, MD 1930 Alcoa Hwy, Ste 435, Knoxville, TN 37920-1520 Ph: (865) 305-8888 | Dr Bobby Clayton Howard, MD 1924 Alcoa Hwy, South 6-south, Knoxville, TN 37920-1511 Ph: (865) 305-8888 |
News Archive
Nycomed announced today that Judge Jose L. Linares of the U.S. District Court for the District of New Jersey has confirmed the jury verdict in favor of Nycomed and Pfizer Inc. The decision upholds the jury verdict issued on April 23, 2010, confirming that the patent is valid and rejecting allegations by the defendants that the patent was invalid as obvious and invalid for double patenting. Against KUDCo, the US generic drug business of the Schwarz Pharma Group, which did not at-risk launch, final Judgment was entered as a result of Judge Jose L. Linares' rulings.
Before you swat away the next fruit fly, consider instead just how similar its biological complexities are to our own.
On 21 February Bill Gates met with Dr. Carlos Martin of the University of Zaragoza and members of his team in Madrid, Spain. The scientists are working on the development of MTBVAC, a new vaccine against tuberculosis (TB). Gates showed great interest in the scientific background of MTBVAC, the most advanced vaccine based on attenuation of Mycobacterium tuberculosis.
Oxis International, Inc., a biotechnology company focused on cancer therapy development and commercialization, announced today that trading in its common stock will resume on Euronext Paris on April 14, 2015.
› Verified 5 days ago
Dr. Periclis Roussis, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 19th St., Suite 401, Knoxville, TN 37916 Phone: 865-331-2020 Fax: 865-331-2019 | |
Dr. George Walton Smith, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 19th St., Suite 401, Knoxville, TN 37916 Phone: 865-541-1975 Fax: 865-541-1976 | |
Dr. Roy Cox Broady, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 19th Street, Suite 509, Knoxville, TN 37916 Phone: 865-524-3208 Fax: 865-522-4322 | |
Courtney Roth, NP Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1926 Alcoa Hwy Ste 370, Knoxville, TN 37920 Phone: 865-305-5622 | |
Dr. Lynlee Marie Wolfe, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1925 Alcoa Hwy, Suite 6-south, Knoxville, TN 37920 Phone: 865-305-8888 | |
Jeffrey A Keenan, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 11126 Kingston Pike, Knoxville, TN 37934 Phone: 865-777-0088 Fax: 865-777-2015 | |
Kristopher J. Kimball, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1934 Alcoa Hwy, Ste 478, Knoxville, TN 37920 Phone: 865-305-5622 Fax: 865-305-4580 |